Pao William has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Based on the provided SEC filing context, Pao William is associated with Immunocore Holdings plc as of the 2026-05-28 filing. Immunocore is a UK-based biotechnology company developing T cell receptor therapies and is publicly traded in the U.S. The available information from the filing does not clearly specify a role (e.g., director, officer) or provide biographical details for this individual, and there is no widely corroborated public biography available. The name could reflect a variation such as William Pao or another naming convention common in SEC disclosures. There is no public record in this context indicating the person is deceased.
Role
Insider
Notability
10/100
Board memberships
Immunocore Holdings plc
Awards & honors
Named in Immunocore Holdings plc SEC filings (2026-05-28)
Based on the provided SEC filing context, Pao William is associated with Immunocore Holdings plc as of the 2026-05-28 filing. Immunocore is a UK-based biotechnology company developing T cell receptor therapies and is publicly traded in the U.S. The available information from the filing does not clearly specify a role (e.g., director, officer) or provide biographical details for…
How many SEC Form 4 filings has Pao William submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Pao William's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
